Inotiv has extensive experience designing preclinical and clinical biomarker strategies to support our clients’ broader clinical development objectives. Working collaboratively with you, we focus on carefully selecting biomarkers to deliver results that support your decision making and produce a significant return on investment.
Our specialized biomarker services include:
Our biomarker strategies encompass the full biological spectrum, including DNA, RNA, protein, cell, and tissue analysis, matched with proven and trusted technology platforms:
Inotiv’s flow cytometry expertise will provide the data needed to get your therapeutic to market faster and provide patients with the treatment they deserve. We specialize in customized flow cytometry panels in early-phase preclinical and clinical trial research and are equipped to process samples from a wide range of matrices, from fresh to cryopreserved.
We analyze samples using a variety of sophisticated approaches, including multimer, phospho-flow cytometry, and receptor occupancy (RO) assays. We utilize dedicated peripheral blood mononuclear cell (PBMC) processing units that are linked to biosafety level 2 (BSL2) cell culture laboratories.
Analytical assay capabilities
We are fully capable of managing samples throughout the complete analytical cycle, with dedicated project, logistics, and sample management policies.
Immunoprofiling and phenotyping assays
Target engagement/PK/PD assays
Robust and proven platforms
Our technology platforms are robust, reliable, and reputable in the clinical field and provide comprehensive and detailed data readouts for your application.
Flow and Cell